Ticker Details
Arcellx, Inc. Common Stock
IPO Date:	February 4, 2022
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$3.99B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.20 | 2.69%
Avg Daily Range (30 D):	$1.44 | 2.12%
Avg Daily Range (90 D):	$1.69 | 2.16%

Institutional Daily Volume
Avg Daily Volume:	.44M
Avg Daily Volume (30 D):	.87M
Avg Daily Volume (90 D):	.66M

Trade Size
Avg Trade Size (Sh.):	53
Avg Trade Size (Sh.) (30 D):	57
Avg Trade Size (Sh.) (90 D):	53

Institutional Trades
Total Institutional Trades:	2,334
Avg Institutional Trade:	$2.78M
Avg Institutional Trade (30 D):	$3.98M
Avg Institutional Trade (90 D):	$3.47M
Avg Institutional Trade Volume:	.05M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$4.39M
Avg Closing Trade (30 D):	$9.63M
Avg Closing Trade (90 D):	$6.77M
Avg Closing Volume:	81.78K

News

Oct 8, 2025 @ 5:00 PM CAR T-Cell Therapy for Multiple Myeloma Market to ... Source: Delveinsight

May 23, 2025 @ 1:10 PM New Data and Deal Flow Signal a Turning Point for ... Source: Prnewswire

May 12, 2025 @ 5:00 PM Blood Cancer Treatment Market Sees Accelerated Gro... Source: Delveinsight

Mar 5, 2025 @ 6:00 PM CAR T-cell Therapy Clinical Trial Pipeline Experie... Source: Delveinsight

Feb 12, 2025 @ 8:22 PM Gilead Ups 2025 Outlook, Eyes Lenacapavir Launch F... Source: Vandana Singh

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS		$-.99	$-.94
Diluted EPS		$-.99	$-.94
Revenue		$4.95M	$7.55M
Gross Profit
Net Income / Loss		$-55.78M	$-52.77M
Operating Income / Loss		$-61.78M	$-58.73M
Cost of Revenue
Net Cash Flow		$16.87M	$-18.73M
PE Ratio